Opendata, web and dolomites

UNLOCK-EDD SIGNED

UNLOCKing next generation computer-guided Enzyme Discovery and Design.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 UNLOCK-EDD project word cloud

Explore the words cloud of the UNLOCK-EDD project. It provides you a very rough idea of what is the project "UNLOCK-EDD" about.

enhanced    engineered    cto    gil    17m    cut    sales    multiple    rely    organically    respected    licensing    zymvol    experimental    90    chemistry    tima    fine    tests    reference    made    model    capture    first    services    lower    enzymes    seeing    industries    synthesis    carg    50    outcomes    11    excellent    molecular    start    9b    pharmaceutical    2018    protein    cso    representing    thanks    advantage    costly    custom    performance    phd    american    platform    67b    team    maria    delivering    predictions    allowed    chemical    physics    uncertain    engineering    reached    biomedical    accelerate    virtual    convert    replace    monza    additional    revenue    industry    pioneering    ceo    hold    global    commodity    thousands    victor    15    biocatalyst    time    fold    obstacle    fast    silico    lucas    computational    royalty    biocatalysts    computer    2022    business    founding    enzyme    entering    reactions    specialized    compounds    house    2024    projected    profile    optimize    aacute    simulations    variants    north    months    power    discovery    members    landed    slow    harness    company    emanuele    reputation    market    grown    breakeven    resolution    industrial    traction    plan    computing   

Project "UNLOCK-EDD" data sheet

The following table provides information about the project.

Coordinator
ZYMVOL BIOMODELING SL 

Organization address
address: PASEO DE RONDA 78 1 1
city: LLEIDA
postcode: 25006
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 1˙859˙281 €
 EC max contribution 1˙301˙496 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-10-01   to  2021-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ZYMVOL BIOMODELING SL ES (LLEIDA) coordinator 1˙301˙496.00

Map

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Project objective

ZYMVOL is start-up specialized in computer-driven biocatalyst discovery and development for the pharmaceutical and fine chemical industry. We harness the power of high-performance computing to identify and optimize custom-made biocatalysts that deliver additional value. Biocatalysts are enzymes that accelerate industrial chemical reactions and have multiple applications for the synthesis of chemical compounds. Engineered enzymes can provide improved performance, representing a unique advantage. The protein engineering market is a fast-growing business estimated to reach 2.67B€ by 2024 (CARG 15%). The main obstacle today to performance enhanced biocatalysts is that current enzyme engineering processes rely on slow and costly experimental tests with uncertain outcomes. Our in-silico engineering platform can rapidly find thousands of enzyme variants delivering reliable predictions, that allow to replace up to 90% of experimental tests, making the enzyme development cost (10-fold lower) and time (cut by 50%) effective. ZYMVOL aims to be the reference in the computer-driven enzyme engineering market and convert molecular modelling in a commodity. In addition to our virtual enzyme sales (we plan to capture €11.17M by 2022 after entering into the North American market), we will promote a royalty-based revenue model from licensing enzymes developed in-house (global enzyme market is projected to reach €9B by 2024). ZYMVOL’s founding team is composed by Maria Fátima Lucas, CEO, Emanuele Monza, CSO and Victor Gil, CTO. All members of the team hold a PhD in chemistry, physics and biomedical engineering. The Company is seeing excellent traction which has allowed it to grown organically in its first 20 months. Thanks to a services-based business model it has already reached breakeven in 2018. The Company has quickly landed some high-profile business and developed a respected reputation by pioneering the access to high resolution computational simulations for all industries.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "UNLOCK-EDD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "UNLOCK-EDD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

ECOBIOMASS (2019)

Achieving unique wines through an efficient production process

Read More  

Preemie (2019)

Personalised nutrition of low-birth-weight infants

Read More  

MycoProScale (2020)

MycoProScale – Creating global markets with a unique large-scale Mycorrhiza production method

Read More